| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.51 | 1e-06 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |